Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Pachanee
PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?
European Clinical Respiratory Journal
Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab as Add‐on Therapy in a Patient With Severe Asthma and OSA
Respirology Case Reports
Pulmonary
Respiratory Medicine
Omalizumab: A Potential Therapy Option for Allergic Bronchopulmonary Aspergillosis (ABPA) in Asthma Patients
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Review of Omalizumab for the Management of Severe Asthma
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Cost-Utility Analysis of Taxane Therapy
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?
Italian Journal of Pediatrics
Child Health
Pediatrics
Perinatology
A Cost-Utility Analysis of Drug Treatments in Patients With HBeAg-positive Chronic Hepatitis B in Thailand
BMC Health Services Research
Health Policy
Utility of Impulse Oscillometry in Patients With Moderate to Severe Persistent Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology